These data indicate that eIF4E promotes PI3K/AKT signaling pathway and Bcl-2/Bax ratio in EC9706, which may imply the possible mechanism of eIF4E induced cisplatin resistance in ESCC. The gene discussed is BCL2; the disease is esophageal squamous cell carcinoma.